Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 157 of the 159 references it cites were found in a registry or an index.

Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review

Open access

Abstract

Perimenopausal depression, occurring shortly before or after menopause, is characterized by symptoms such as emotional depression, anxiety, and stress, often accompanied by endocrine dysfunction, particularly hypogonadism and senescence. Current treatments for perimenopausal depression primarily provide symptomatic relief but often come with undesirable side effects. The development of agents targeting the specific pathologies of perimenopausal depression has been relatively slow. The erratic fluctuations in estrogen and progesterone levels during the perimenopausal stage expose women to the risk of developing perimenopausal-associated depression. These hormonal changes trigger the production of proinflammatory mediators and induce oxidative stress, leading to progressive neuronal damage. This review serves as a comprehensive overview of the underlying mechanisms contributing to perimenopausal depression. It aims to shed light on the complex relationship between perimenopausal hormones, neurotransmitters, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression. By summarizing the intricate interplay between hormonal fluctuations, neurotransmitter activity, brain-derived neurotrophic factors, chronic inflammation, oxidative stress, and perimenopausal depression, this review aims to stimulate further research in this field. The hope is that an increased understanding of these mechanisms will pave the way for the development of more effective therapeutic targets, ultimately reducing the risk of depression during the menopausal stage for the betterment of psychological wellbeing.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/biomedicines12010184

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Estrogen deficiency and HPA axis dysregulation. (1) Neurons in the hypothalamus release the hypothalamic neuropeptides corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP). (2) CRH and AVP promote a posttranslational cleavage of anterior pituitary pro-opiomelanocortin mRNA (POMC), resulting in the synthesis and secretion of adrenocorticotrophin (ACTH). (3) ACTH stimulates the release of glucocorticoids and mineralocorticoids derived from the adrenal glands. (4) The hippocampus, as an important site of glucocorticoid receptor (GR) and mineralocorticoid (MR) receptors mediated negative feedback regulation, plays a vital role in the end stage of this stress feedback process. (5) TNF-α and IL-1β trigger the imbalance of the HPA axis by inhibiting the transcriptions of c-fos and AVP. (6) Estrogen is able to regulate the hypothalamic response to stress by regulating CRH, oxytocin, and AVP gene expression in hypothalamic neurons and the excitatory inputs to the PVN. Perimenopausal estrogen deficiency leads to weakened regulation of the HPA axis response to external stress. (7) Estrogen can block the actions of CRH on anterior pituitary corticotrophs by increasing the expression of CRH-BP and restricting the amounts of bioactive CRH. Perimenopausal estrogen deficiency increases the sensitivity of the pituitary gland to CRH, thereby resulting in the overactivation of the HPA axis.
Figure 1 Estrogen deficiency and HPA axis dysregulation. (1) Neurons in the hypothalamus release the hypothalamic neuropeptides corticotrophin-releasing hormone (CRH) and arginine vasopressin (AVP). (2) CRH and AVP promote a posttranslational cleavage of anterior pituitary pro-opiomelanocortin mRNA (POMC), resulting in the synthesis and secretion of adrenocorticotrophin (ACTH). (3) ACTH stimulates the release of glucocorticoids and mineralocorticoids derived from the adrenal glands. (4) The hippocampus, as an important site of glucocorticoid receptor (GR) and mineralocorticoid (MR) receptors mediated negative feedback regulation, plays a vital role in the end stage of this stress feedback process. (5) TNF-α and IL-1β trigger the imbalance of the HPA axis by inhibiting the transcriptions of c-fos and AVP. (6) Estrogen is able to regulate the hypothalamic response to stress by regulating CRH, oxytocin, and AVP gene expression in hypothalamic neurons and the excitatory inputs to the PVN. Perimenopausal estrogen deficiency leads to weakened regulation of the HPA axis response to external stress. (7) Estrogen can block the actions of CRH on anterior pituitary corticotrophs by increasing the expression of CRH-BP and restricting the amounts of bioactive CRH. Perimenopausal estrogen deficiency increases the sensitivity of the pituitary gland to CRH, thereby resulting in the overactivation of the HPA axis.CC BY · PubMed Central
Figure 2 Neuroinflammatory pathway following estrogen deficiency. (1) Estrogen can inhibit the secretion of inflammatory factors by T cells and macrophages, and the decrease in estrogen levels leads to chronic inflammation during perimenopause, resulting in an increase in inflammatory mediators in peripheral blood. (2) These peripheral cytokines will directly or indirectly reach the brain via different specific or non-specific pathways. (3) In premenopause, β-estradiol inhibits microglia-mediated astrocytic activation to alleviate neuroinflammation and the secretion of inflammatory mediators by microglia. On the other hand, in perimenopause, estrogen deficiency allows inflammatory cytokines to activate microglia in the brain, which then produce other inflammatory mediators. (4) IL-β, IL-6, and TNF-α reduce the synthesis of 5-HT by stimulating indoleamine 2,3-dioxygenase (IDO). (5) IDO can convert tryptophan into kynurenine, and the activation of the kynurenine pathway results in the production of ROS and RNS. On the other hand, superoxide anion radicals can cause superinduction of the kynurenine pathway. (6) ROS and RNS reduce the synthesis of 5-HT by stimulating IDO and the kynurenine pathway. (7) Neuroglia secrete serotonin, which then promotes BDNF secretion. (8) Similarly, estrogen can promote the synthesis and secretion of BDNF; therefore, after menopause, insufficient estrogen can lead to a decrease in BDNF synthesis. (9) IL-β, IL-6, and TNF-α can inhibit the neuroprotective effect of BDNF. (10) IL-β, IL-6, TNF-α can promote the production of ROS in mitochondria. Furthermore, the ROS can also promote the synthesis and release of inflammatory factors. (11) Estrogen can reduce ROS production by promoting the synthesis of antioxidant enzymes, and insufficient estrogen during perimenopause leads to an increase in ROS. (12) ROS can lead to lipid, DNA, and protein oxidation and damage in the brain. (13) ROS reduces the production of monoaminergic neurotransmitters and other aminergic compounds. (14) IL-β decreases the rate-limiting enzyme in noradrenaline. (15) IL-β, IL-6, and TNF-α can suppress GABAergic inhibitory transmission.
Figure 2 Neuroinflammatory pathway following estrogen deficiency. (1) Estrogen can inhibit the secretion of inflammatory factors by T cells and macrophages, and the decrease in estrogen levels leads to chronic inflammation during perimenopause, resulting in an increase in inflammatory mediators in peripheral blood. (2) These peripheral cytokines will directly or indirectly reach the brain via different specific or non-specific pathways. (3) In premenopause, β-estradiol inhibits microglia-mediated astrocytic activation to alleviate neuroinflammation and the secretion of inflammatory mediators by microglia. On the other hand, in perimenopause, estrogen deficiency allows inflammatory cytokines to activate microglia in the brain, which then produce other inflammatory mediators. (4) IL-β, IL-6, and TNF-α reduce the synthesis of 5-HT by stimulating indoleamine 2,3-dioxygenase (IDO). (5) IDO can convert tryptophan into kynurenine, and the activation of the kynurenine pathway results in the production of ROS and RNS. On the other hand, superoxide anion radicals can cause superinduction of the kynurenine pathway. (6) ROS and RNS reduce the synthesis of 5-HT by stimulating IDO and the kynurenine pathway. (7) Neuroglia secrete serotonin, which then promotes BDNF secretion. (8) Similarly, estrogen can promote the synthesis and secretion of BDNF; therefore, after menopause, insufficient estrogen can lead to a decrease in BDNF synthesis. (9) IL-β, IL-6, and TNF-α can inhibit the neuroprotective effect of BDNF. (10) IL-β, IL-6, TNF-α can promote the production of ROS in mitochondria. Furthermore, the ROS can also promote the synthesis and release of inflammatory factors. (11) Estrogen can reduce ROS production by promoting the synthesis of antioxidant enzymes, and insufficient estrogen during perimenopause leads to an increase in ROS. (12) ROS can lead to lipid, DNA, and protein oxidation and damage in the brain. (13) ROS reduces the production of monoaminergic neurotransmitters and other aminergic compounds. (14) IL-β decreases the rate-limiting enzyme in noradrenaline. (15) IL-β, IL-6, and TNF-α can suppress GABAergic inhibitory transmission.CC BY · PubMed Central
Figure 3 The antioxidant mechanism of estrodiol. (1) Estradiol binds to G-protein-coupled receptor 30 on the cell membrane. (2) GPR30 activation by estradiol elicited the SRC/EGFR/PI3K/Akt signaling pathway. (3) The activation of the GPR30/SRC/EGFR/PI3K/Akt signaling pathway leads to Nrf2 dissociation from Keap1. (4) Nrf2 translocates into the nucleus. Then the heterodimerization of NRF2 with small Maf proteins in AREs occurs and activates transcription of SOD, CAT, HO-1, GPxs, and so on. (5) Insufficient estrogen during perimenopause results in KEAP1-recruited CUL3, RBX, and NRF2 to degrade NRF2 through ubiquitination and ultimately leads to the decrease in antioxidant substances, while the increase in ROS leads to increased levels of oxidative stress and nerve damage in perimenopausal women.
Figure 3 The antioxidant mechanism of estrodiol. (1) Estradiol binds to G-protein-coupled receptor 30 on the cell membrane. (2) GPR30 activation by estradiol elicited the SRC/EGFR/PI3K/Akt signaling pathway. (3) The activation of the GPR30/SRC/EGFR/PI3K/Akt signaling pathway leads to Nrf2 dissociation from Keap1. (4) Nrf2 translocates into the nucleus. Then the heterodimerization of NRF2 with small Maf proteins in AREs occurs and activates transcription of SOD, CAT, HO-1, GPxs, and so on. (5) Insufficient estrogen during perimenopause results in KEAP1-recruited CUL3, RBX, and NRF2 to degrade NRF2 through ubiquitination and ultimately leads to the decrease in antioxidant substances, while the increase in ROS leads to increased levels of oxidative stress and nerve damage in perimenopausal women.CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 159 references

Research works printed but not linked: 1

  1. Delgado, 2000, Depression: The case for a monoamine deficiency, J. Clin. Psychiatry, 61, 7

Cited by

See all 68

Metadata

Authors
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T.
Affiliations
  • UCSI University (MY)
  • Universiti Putra Malaysia (MY)
  • I-Shou University (TW)
Corresponding author
  • Ho, Yu-Cheng
  • Lee, Ming Tatt
Venue
Biomedicines
Publisher
MDPI AG
Published
2024-01-15
Volume
12
Issue
1
Pages
184
ISSN
2227-9059 (ISSN-L)
OpenAlex
W4390880590
Cited by
68
References
159
Citations by year
2026: 25 · 2025: 35 · 2024: 8
FWCI
3.97
Type
journal article
Language
en
Open access
Locations
  • Biomedicines (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • Universiti Putra Malaysia Institutional Repository (Universiti Putra Malaysia) (acceptedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Funders
  • Fundamental Research Grant Scheme, Ministry of Higher Education, Malaysia (FRGS/1/2021/SKK06/UCSI/02/4, FRGS/1/2021/WAB13/UCSI/02/1, MOST 108–2320-B-214–011-MY3, MOST 111–2320-B-214-002-MY3, REIG-FPS-2023/043, REIG-FPS-2022/006)
  • Ministry of Science and Technology, Taipei, Taiwan (FRGS/1/2021/SKK06/UCSI/02/4, FRGS/1/2021/WAB13/UCSI/02/1, MOST 108–2320-B-214–011-MY3, MOST 111–2320-B-214-002-MY3, REIG-FPS-2023/043, REIG-FPS-2022/006)
  • UCSI University Research Excellence and Innovation Grant, Malaysia (FRGS/1/2021/SKK06/UCSI/02/4, FRGS/1/2021/WAB13/UCSI/02/1, MOST 108–2320-B-214–011-MY3, MOST 111–2320-B-214-002-MY3, REIG-FPS-2023/043, REIG-FPS-2022/006)
Topics
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Menopause: Health Impacts and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Endocrinology › Estrogen and related hormone effects
  • Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
Keywords
perimenopausal depression, menopause, oxidative stress, neuroinflammation, estrogen, progesterone, hypogonadism, brain-derived neurotrophic factor, neurotransmitters, chronic inflammation, neuronal injury, therapeutic target

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review. https://app.cochat.ai/papers/10.3390/biomedicines12010184
The paper
Liang, G., Kow, A. S. F., Yusof, R., Tham, C. L., Ho, Y.-C., & Lee, M. T. (2024). Menopause-Associated Depression: Impact of Oxidative Stress and Neuroinflammation on the Central Nervous System—A Review. Biomedicines. https://doi.org/10.3390/biomedicines12010184

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.